PCN521 THE FINANCIAL IMPACT OF AFATINIB REIMBURSEMENT FOR EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER: THE REAL-WORLD EVIDENCE IN TAIWAN
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.713
https://www.valueinhealthjournal.com/article/S1098-3015(19)33091-8/fulltext
Title :
PCN521 THE FINANCIAL IMPACT OF AFATINIB REIMBURSEMENT FOR EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER: THE REAL-WORLD EVIDENCE IN TAIWAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33091-8&doi=10.1016/j.jval.2019.09.713
First page :
Section Title :
Open access? :
No
Section Order :
10625